MARKET

JAZZ

JAZZ

Jazz Pharmaceuticals Plc
NASDAQ
227.97
+4.36
+1.95%
Opening 15:58 05/12 EDT
OPEN
225.30
PREV CLOSE
223.61
HIGH
229.20
LOW
223.85
VOLUME
660.52K
TURNOVER
--
52 WEEK HIGH
230.40
52 WEEK LOW
99.13
MARKET CAP
14.30B
P/E (TTM)
2144.59
1D
5D
1M
3M
1Y
5Y
1D
Jazz Pharmaceuticals (JAZZ) Is Up 8.5% After Q1 Profit Rebound And Ziihera Priority Review – Has The Bull Case Changed?
Simply Wall St · 1d ago
International Markets and Jazz (JAZZ): A Deep Dive for Investors
NASDAQ · 1d ago
Needham Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
TipRanks · 1d ago
Weekly Report: what happened at JAZZ last week (0504-0508)?
Weekly Report · 1d ago
Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Its Recent Share Price Surge
Simply Wall St · 2d ago
Jazz Pharmaceuticals plc Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Simply Wall St · 4d ago
Werewolf Therapeutics Q1 net loss narrows to $13.5 million; R&D expenses drop to $8.2 million
PUBT · 5d ago
Jazz Pharmaceuticals price target raised to $245 from $226 at Morgan Stanley
TipRanks · 5d ago
More
About JAZZ
Jazz Pharmaceuticals plc is a global biopharmaceutical company. It is engaged in developing medicines for people with serious diseases, often with limited or no therapeutic options. It has a diverse portfolio of marketed medicines, including therapies for sleep disorders and epilepsy, and a portfolio of cancer treatments. Its lead-marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Ziihera (zanidatamab-hrii), and Enrylaze (recombinant crisantaspase). Its product candidates include Zanidatamab, Vyxeos, JZP815, JZP898, JZP441, and others. Xywav is used for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy. The Company, through Chimerix, Inc., also owns a clinical asset, dordaviprone, a novel small molecule treatment in development for H3 K27M-mutant diffuse glioma.

Webull offers Jazz Pharmaceuticals PLC stock information, including NASDAQ: JAZZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAZZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAZZ stock methods without spending real money on the virtual paper trading platform.